13F-HR filed by Decheng Capital Management III (Cayman), LLC
Decheng Capital Management III (Cayman), LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-08, with 26 holding rows worth $275,828,000.
- Accession
- 0001104659-22-115855
- Filer
- CIK 1747821
- Filed
- 2022-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 26 entries on the cover page, a total value of $275,828,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $275,829,000 with VALUE read as thousands by filing date, 13F file number 028-22474. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 6,708,288 | $48,300,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,824,583 | $39,520,000 | thousands by filing date | |
| CUE HEALTH INC | 229790100 | COM | 8,980,909 | $27,033,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 130,138 | $24,829,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 869,790 | $22,754,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 250,000 | $14,753,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 623,342 | $12,068,000 | thousands by filing date | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 359,554 | $10,240,000 | thousands by filing date | |
| EQUILLIUM INC | 29446K106 | COM | 4,447,308 | $9,873,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,463,872 | $8,505,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 580,000 | $8,248,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 526,329 | $7,437,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 904,268 | $6,113,000 | thousands by filing date | |
| Pyxis Oncology, Inc (formerly Apexigen) | 03759B102 | COM | 1,894,551 | $5,115,000 | thousands by filing date | |
| BEYONDSPRING INC | G10830100 | SHS | 4,958,143 | $4,909,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 78,900 | $4,883,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 714,285 | $4,207,000 | thousands by filing date | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 210,000 | $3,805,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 23,014 | $3,149,000 | thousands by filing date | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 3,418,929 | $3,002,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 5,529 | $1,952,000 | thousands by filing date | |
| AtriCure Inc. | 004963C20 | COM | 46,259 | $1,809,000 | thousands by filing date | |
| SCYNEXIS INC | 811292200 | COM NEW | 555,555 | $1,333,000 | thousands by filing date | |
| OWLET INC | 69120X107 | COM | 898,400 | $961,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 300,000 | $636,000 | thousands by filing date | |
| Ohr Pharmaceutical Inc | 64132K102 | COM | 1,000,000 | $395,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-115855 | this filing | 2022-11-08 | acceptance time not in the bulk data set |